Communication Equipment
Build Your Comparison
Side-by-side financial analysisStock Comparison
CRNT vs NVDA vs QCOM vs MRVL vs AVGO
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
CRNT vs NVDA vs QCOM vs MRVL vs AVGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Communication Equipment | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $243M | $5.10T | $238.32B | $271.70B | $1.96T |
| Revenue (TTM) | $335M | $253.49B | $44.49B | $8.72B | $81.70B |
| Net Income (TTM) | $-2M | $159.61B | $9.92B | $2.53B | $34.49B |
| Gross Margin | 34.4% | 74.1% | 54.8% | 50.6% | 67.0% |
| Operating Margin | 3.0% | 64.0% | 25.5% | 16.2% | 46.4% |
| Forward P/E | 20.1x | 23.6x | 21.1x | 76.8x | 35.5x |
| Total Debt | $50M | $11.41B | $16.37B | $4.79B | $65.14B |
| Cash & Equiv. | $38M | $10.61B | $7.84B | $2.64B | $16.18B |
CRNT vs NVDA vs QCOM vs MRVL vs AVGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Ceragon Networks Lt… (CRNT) | 100 | 125.6 | +25.6% |
| NVIDIA Corporation (NVDA) | 100 | 2217.8 | +2117.8% |
| QUALCOMM Incorporat… (QCOM) | 100 | 247.9 | +147.9% |
| Marvell Technology,… (MRVL) | 100 | 885.9 | +785.9% |
| Broadcom Inc. (AVGO) | 100 | 1303.4 | +1203.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRNT vs NVDA vs QCOM vs MRVL vs AVGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CRNT is the #2 pick in this set and the best alternative if value is your priority.
- Lower P/E (20.1x vs 35.5x)
NVDA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 65.5%, EPS growth 66.7%, 3Y rev CAGR 100.0%
- 176.4% 10Y total return vs MRVL's 29.9%
- Lower volatility, beta 1.83, Low D/E 7.3%, current ratio 3.91x
- PEG 0.25 vs QCOM's 10.13
QCOM ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 22 yrs, beta 1.94, yield 1.5%
- Beta 1.94, yield 1.5%, current ratio 2.82x
- 1.5% yield, 22-year raise streak, vs NVDA's 0.0%, (1 stock pays no dividend)
MRVL is the clearest fit if your priority is momentum.
- +314.7% vs CRNT's +17.9%
Among these 5 stocks, AVGO doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 65.5% revenue growth vs CRNT's -14.1% | |
| Value | Lower P/E (20.1x vs 35.5x) | |
| Quality / Margins | 63.0% margin vs CRNT's -0.7% | |
| Stability / Safety | Beta 1.83 vs MRVL's 2.72, lower leverage | |
| Dividends | 1.5% yield, 22-year raise streak, vs NVDA's 0.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +314.7% vs CRNT's +17.9% | |
| Efficiency (ROA) | 83.1% ROA vs CRNT's -0.8%, ROIC 81.8% vs 4.7% |
CRNT vs NVDA vs QCOM vs MRVL vs AVGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CRNT vs NVDA vs QCOM vs MRVL vs AVGO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NVDA leads in 2 of 6 categories
CRNT leads 1 • MRVL leads 1 • QCOM leads 1 • AVGO leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NVDA leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVDA is the larger business by revenue, generating $253.5B annually — 756.5x CRNT's $335M. NVDA is the more profitable business, keeping 63.0% of every revenue dollar as net income compared to CRNT's -0.7%. On growth, NVDA holds the edge at +85.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $335M | $253.5B | $44.5B | $8.7B | $81.7B |
| EBITDAEarnings before interest/tax | $24M | $165.5B | $12.8B | $2.7B | $46.6B |
| Net IncomeAfter-tax profit | -$2M | $159.6B | $9.9B | $2.5B | $34.5B |
| Free Cash FlowCash after capex | $23M | $119.1B | $12.5B | $1.7B | $36.0B |
| Gross MarginGross profit ÷ Revenue | +34.4% | +74.1% | +54.8% | +50.6% | +67.0% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +64.0% | +25.5% | +16.2% | +46.4% |
| Net MarginNet income ÷ Revenue | -0.7% | +63.0% | +22.3% | +29.0% | +42.2% |
| FCF MarginFCF ÷ Revenue | +6.8% | +47.0% | +28.1% | +19.1% | +44.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.1% | +85.2% | -3.5% | +27.6% | +47.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -48.0% | +2.1% | +173.0% | -80.7% | +85.4% |
Valuation Metrics
CRNT leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 43.0x trailing earnings, NVDA trades at a 57% valuation discount to MRVL's 101.2x P/E. Adjusting for growth (PEG ratio), NVDA offers better value at 0.45x vs QCOM's 21.70x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $243M | $5.10T | $238.3B | $271.7B | $1.96T |
| Enterprise ValueMkt cap + debt − cash | $254M | $5.10T | $246.8B | $273.8B | $2.01T |
| Trailing P/EPrice ÷ TTM EPS | -115.88x | 43.00x | 45.13x | 101.17x | 86.24x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.15x | 23.60x | 21.06x | 76.78x | 35.55x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.45x | 21.70x | — | 1.73x |
| EV / EBITDAEnterprise value multiple | 10.01x | 38.31x | 17.69x | 104.16x | 58.55x |
| Price / SalesMarket cap ÷ Revenue | 0.72x | 23.63x | 5.38x | 33.16x | 30.63x |
| Price / BookPrice ÷ Book value/share | 1.40x | 32.84x | 11.78x | 18.88x | 24.56x |
| Price / FCFMarket cap ÷ FCF | 13.52x | 52.79x | 18.59x | 194.57x | 72.71x |
Profitability & Efficiency
NVDA leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
NVDA delivers a 111.7% return on equity — every $100 of shareholder capital generates $112 in annual profit, vs $-1 for CRNT. NVDA carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVGO's 0.80x. On the Piotroski fundamental quality scale (0–9), AVGO scores 8/9 vs CRNT's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -1.4% | +111.7% | +40.2% | +16.8% | +41.0% |
| ROA (TTM)Return on assets | -0.8% | +83.1% | +18.4% | +11.1% | +19.7% |
| ROICReturn on invested capital | +4.7% | +81.8% | +29.1% | +6.0% | +14.9% |
| ROCEReturn on capital employed | +5.7% | +97.2% | +28.9% | +7.2% | +16.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 6 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.29x | 0.07x | 0.77x | 0.33x | 0.80x |
| Net DebtTotal debt minus cash | $11M | $807M | $8.5B | $2.2B | $49.0B |
| Cash & Equiv.Liquid assets | $38M | $10.6B | $7.8B | $2.6B | $16.2B |
| Total DebtShort + long-term debt | $50M | $11.4B | $16.4B | $4.8B | $65.1B |
| Interest CoverageEBIT ÷ Interest expense | 0.65x | 636.02x | 17.60x | 15.67x | 12.78x |
Total Returns (Dividends Reinvested)
MRVL leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVDA five years ago would be worth $113,232 today (with dividends reinvested), compared to $7,143 for CRNT. Over the past 12 months, MRVL leads with a +314.7% total return vs CRNT's +17.9%. The 3-year compound annual growth rate (CAGR) favors MRVL at 72.3% vs CRNT's 9.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +23.3% | +11.7% | +31.8% | +247.6% | +18.5% |
| 1-Year ReturnPast 12 months | +17.9% | +45.0% | +49.5% | +314.7% | +64.7% |
| 3-Year ReturnCumulative with dividends | +31.1% | +381.7% | +97.3% | +411.8% | +381.6% |
| 5-Year ReturnCumulative with dividends | -28.6% | +1032.3% | +82.2% | +474.5% | +809.0% |
| 10-Year ReturnCumulative with dividends | +60.7% | +17642.9% | +372.1% | +2986.0% | +2612.3% |
| CAGR (3Y)Annualised 3-year return | +9.4% | +68.9% | +25.4% | +72.3% | +68.9% |
Risk & Volatility
Evenly matched — NVDA and MRVL each lead in 1 of 2 comparable metrics.
Risk & Volatility
NVDA is the less volatile stock with a 1.83 beta — it tends to amplify market swings less than MRVL's 2.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MRVL currently trades 94.1% from its 52-week high vs CRNT's 82.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.04x | 1.83x | 1.94x | 2.72x | 2.12x |
| 52-Week HighHighest price in past year | $3.29 | $236.54 | $259.92 | $329.88 | $495.00 |
| 52-Week LowLowest price in past year | $1.82 | $142.03 | $121.99 | $61.44 | $244.17 |
| % of 52W HighCurrent price vs 52-week peak | +82.1% | +89.1% | +87.0% | +94.1% | +83.1% |
| RSI (14)Momentum oscillator 0–100 | 46.5 | 45.3 | 50.7 | 61.2 | 46.1 |
| Avg Volume (50D)Average daily shares traded | 636K | 148.9M | 21.8M | 40.4M | 23.9M |
Analyst Outlook
QCOM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CRNT as "Buy", NVDA as "Buy", QCOM as "Hold", MRVL as "Buy", AVGO as "Buy". Consensus price targets imply 57.4% upside for CRNT (target: $4) vs -22.3% for MRVL (target: $241). For income investors, QCOM offers the higher dividend yield at 1.52% vs AVGO's 0.56%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $4.25 | $316.79 | $191.05 | $241.46 | $498.19 |
| # AnalystsCovering analysts | 6 | 79 | 69 | 73 | 58 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | +1.5% | +0.1% | +0.6% |
| Dividend StreakConsecutive years of raises | — | 2 | 22 | 0 | 16 |
| Dividend / ShareAnnual DPS | — | $0.04 | $3.44 | $0.24 | $2.30 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.8% | +3.7% | +0.8% | +0.3% |
NVDA leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CRNT leads in 1 (Valuation Metrics). 1 tied.
CRNT vs NVDA vs QCOM vs MRVL vs AVGO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CRNT or NVDA or QCOM or MRVL or AVGO a better buy right now?
For growth investors, NVIDIA Corporation (NVDA) is the stronger pick with 65.
5% revenue growth year-over-year, versus -14. 1% for Ceragon Networks Ltd. (CRNT). NVIDIA Corporation (NVDA) offers the better valuation at 43. 0x trailing P/E (23. 6x forward), making it the more compelling value choice. Analysts rate Ceragon Networks Ltd. (CRNT) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CRNT or NVDA or QCOM or MRVL or AVGO?
On trailing P/E, NVIDIA Corporation (NVDA) is the cheapest at 43.
0x versus Marvell Technology, Inc. at 101. 2x. On forward P/E, Ceragon Networks Ltd. is actually cheaper at 20. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NVIDIA Corporation wins at 0. 25x versus QUALCOMM Incorporated's 10. 13x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CRNT or NVDA or QCOM or MRVL or AVGO?
Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1032%, compared to -28.
6% for Ceragon Networks Ltd. (CRNT). Over 10 years, the gap is even starker: NVDA returned +176. 4% versus CRNT's +60. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CRNT or NVDA or QCOM or MRVL or AVGO?
By beta (market sensitivity over 5 years), NVIDIA Corporation (NVDA) is the lower-risk stock at 1.
83β versus Marvell Technology, Inc. 's 2. 72β — meaning MRVL is approximately 49% more volatile than NVDA relative to the S&P 500. On balance sheet safety, NVIDIA Corporation (NVDA) carries a lower debt/equity ratio of 7% versus 80% for Broadcom Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CRNT or NVDA or QCOM or MRVL or AVGO?
By revenue growth (latest reported year), NVIDIA Corporation (NVDA) is pulling ahead at 65.
5% versus -14. 1% for Ceragon Networks Ltd. (CRNT). On earnings-per-share growth, the picture is similar: Marvell Technology, Inc. grew EPS 401. 0% year-over-year, compared to -108. 6% for Ceragon Networks Ltd.. Over a 3-year CAGR, NVDA leads at 100. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CRNT or NVDA or QCOM or MRVL or AVGO?
NVIDIA Corporation (NVDA) is the more profitable company, earning 55.
6% net margin versus -0. 6% for Ceragon Networks Ltd. — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus 3. 3% for CRNT. At the gross margin level — before operating expenses — NVDA leads at 71. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CRNT or NVDA or QCOM or MRVL or AVGO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NVIDIA Corporation (NVDA) is the more undervalued stock at a PEG of 0. 25x versus QUALCOMM Incorporated's 10. 13x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Ceragon Networks Ltd. (CRNT) trades at 20. 1x forward P/E versus 76. 8x for Marvell Technology, Inc. — 56. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRNT: 57. 4% to $4. 25.
08Which pays a better dividend — CRNT or NVDA or QCOM or MRVL or AVGO?
In this comparison, QCOM (1.
5% yield), AVGO (0. 6% yield) pay a dividend. CRNT, NVDA, MRVL do not pay a meaningful dividend and should not be held primarily for income.
09Is CRNT or NVDA or QCOM or MRVL or AVGO better for a retirement portfolio?
For long-horizon retirement investors, QUALCOMM Incorporated (QCOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.
5% yield, +372. 1% 10Y return). Marvell Technology, Inc. (MRVL) carries a higher beta of 2. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (QCOM: +372. 1%, MRVL: +29. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CRNT and NVDA and QCOM and MRVL and AVGO?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CRNT is a small-cap quality compounder stock; NVDA is a mega-cap high-growth stock; QCOM is a large-cap quality compounder stock; MRVL is a large-cap high-growth stock; AVGO is a mega-cap high-growth stock. QCOM, AVGO pay a dividend while CRNT, NVDA, MRVL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.